Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractRelaxation of an induced defense after exclusion of herbivores: spines on Acacia drepanolobium    Next Abstract"Pimenta dioica and Pimenta racemosa: GC-based metabolomics for the assessment of seasonal and organ variation in their volatile components, in silico and in vitro cytotoxic activity estimation" »

Med Gas Res


Title:Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease
Author(s):Yousefi B; Banihashemian SZ; Feyzabadi ZK; Hasanpour S; Kokhaei P; Abdolshahi A; Emadi A; Eslami M;
Address:"Department of Immunology, Semnan University of Medical Sciences, Semnan, Iran. Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran. Department of Microbiology and Mycology, Science and Research Branch, Islamic Azad University, Tehran, Iran. Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden. Food Safety Research Center (Salt), Semnan University of Medical Sciences, Semnan, Iran. Deputy of Research and Technology, Semnan University of Medical Sciences, Semnan, Iran. Department of Bacteriology and Virology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran"
Journal Title:Med Gas Res
Year:2022
Volume:12
Issue:2
Page Number:33 - 40
DOI: 10.4103/2045-9912.325989
ISSN/ISBN:2045-9912 (Electronic) 2045-9912 (Linking)
Abstract:"Atmospheric ozone is produced when nitrogen oxides react with volatile organic compounds. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome contains a unique N-terminal fragment in the Spike protein, which allows it to bind to air pollutants in the environment. 'Our approach in this review is to study ozone and its effect on the SARS-CoV-2 virus and patients with coronavirus disease 2019 (COVID-19). Article data were collected from PubMed, Scopus, and Google Scholar databases. Ozone therapy has antiviral properties, improves blood flow, facilitates the transfer of oxygen in hypoxemic tissues, and reduces blood coagulation phenomena in COVID-19 patients. Ozone has immunomodulatory effects by modulating cytokines (reduction of interleukin-1, interleukin-6, tumor necrosis factor-alpha, and interleukin-10), induction of interferon-gamma, anti-inflammatory properties by modulating NOD-, LRR- and pyrin domain-containing protein 3, inhibition of cytokine storm (blocking nuclear factor-kappaB and stimulating nuclear factor erythroid 2-related factor 2 pathway), stimulates cellular/humoral immunity/phagocytic function and blocks angiotensin-converting enzyme 2. In direct oxygen-ozone injection, oxygen reacts with several biological molecules such as thiol groups in albumin to form ozonoids. Intravenous injection of ozonated saline significantly increases the length of time a person can remain hypoxic. The rectal ozone protocol is rectal ozone insufflation, resulting in clinical improvement in oxygen saturation and biochemical improvement (fibrinogen, D-dimer, urea, ferritin, LDH, interleukin-6, and C-reactive protein). In general, many studies have shown the positive effect of ozone therapy as a complementary therapy in the recovery of COVID-19 patients. All the findings indicate that systemic ozone therapy is nontoxic and has no side effects in these patients"
Keywords:*covid-19 Cytokine Release Syndrome Humans Oxygen *Ozone/therapeutic use SARS-CoV-2 Covid-19 Mers Sars coronavirus immunity ozone;
Notes:"MedlineYousefi, Bahman Banihashemian, Seyedeh Zahra Feyzabadi, Zahra Khatibiyan Hasanpour, Sahar Kokhaei, Parviz Abdolshahi, Anna Emadi, Alireza Eslami, Majid eng Review Australia 2021/10/23 Med Gas Res. 2022 Apr-Jun; 12(2):33-40. doi: 10.4103/2045-9912.325989"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 19-12-2024